SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-07
👔
ImmunityBio, Inc.
@IBRX_InsiderForm 4 Filing: Cohen Cheryl Sells $1.4M of $IBRX
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
ImmunityBio, Inc.
Ticker: $IBRX
Transaction Value
$1.4M
Price/Share: $7.55
transaction date
2026-07-02
Shares: 187,189
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Cohen Cheryl, holds the title of Director at ImmunityBio, Inc..
On 2026-07-02, the insider transacted 187,189 shares.The shares were transacted at a weighted average price of $7.55 per share, resulting in a total market-relevant value of $1.4M.
Executive Summary Summary
Cohen Cheryl (Director) sold $1.4M of $IBRX
Post-Transaction Position: 125,386 shares
SEC Accession No: 0001529371-26-000008 (CIK: 1529371)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.